Introduction {#s1}
============

γδ T cells, together with αβ T cells and B cells, are the only cells in mammals capable of generating diverse antigenic receptors by somatic gene rearrangement, which enables them to specifically recognize and respond to a vast array of antigens. However, while the essential role of αβ T cells and B cells for the induction of long-lasting protective immune responses is undisputed, γδ T cells due to their low abundance in peripheral lymphoid organs have been often ignored by the scientific community ([@bib2]). This has changed in the past decade, as it became evident that γδ T cells are important players not only during protective immune reactions ([@bib25]), but also in various models of autoimmune disease ([@bib31]; [@bib7]; [@bib29]).

Several features distinguish γδ T cells from their αβ counterparts (reviewed in [@bib46]). Most notably, γδ T cells recognize qualitatively different antigens. The scope of the potential antigens has not been revealed entirely, but known targets include non-classical MHC molecules ([@bib40]), phosophoantigens ([@bib9]) as well as a discrete set of non-self proteins ([@bib50]). The second main characteristic of γδ T cells is their ability for rapid production of pro-inflammatory cytokines such as INF-γ and IL-17 independent of TCR engagement ([@bib42]). This feature has been suggested to be hardwired in developing γδ T cells already during thymic development, probably in dependency of self-antigen recognition ([@bib22]). The surface molecule CD27, which belongs to the tumor necrosis (TNF) receptor superfamily has been shown to distinguish IFN-γ-producing from IL-17-producing γδ T cells ([@bib34]), as does the differential expression of the transcription factors T-bet and RORγt and certain chemokine receptors such as CCR6 ([@bib17]).

Although the genetic diversity of the TCR γδ locus would theoretically allow an even higher number of different TCR specificities than for αβ T cells ([@bib5]), γδ T cells show a remarkable limitation in their TCR variability. Moreover, γδ T cells with a given TCR specificity often home to non-lymphoid organs, where the majority of mature γδ T cells can be found. The prime example of tissue homing-behavior is observed in dendritic epidermal T cells (DETCs), which are found in the murine epidermis and almost exclusively express a clonotypic TCR consisting of the Vγ5 and Vδ1 chains ([@bib3]). Vγ5^+^ DETCs are among the very first T cells to develop during embryogenesis, populating the epidermis already around day 15/16 of fetal development ([@bib48]). Also other subsets of γδ T cells, such as Vγ4^+ ^γδ T cells (mostly IL-17 producers), which migrate predominantly to the dermis and lung tissue, have been shown to develop only early in ontogeny ([@bib2]; [@bib18]; [@bib33]).

The underpinning signaling pathways and precise developmental program as well as the mechanisms underlying the pre-determined cytokine profile of γδ T cells have been only partially resolved. One major step forward was the identification of Skint-1 (Selection and upkeep of intraepithelial T cells-1), which has an essential function for the development of Vγ5^+^ DETCs ([@bib25]; [@bib23]; [@bib6]). Expression of Skint-1 by medullary thymic epithelial cells (mTECs) ([@bib4]) leads to a signaling cascade in developing γδ thymocytes that induces the typical gene expression profile of DETCs, concomitant to their preferential homing to the skin ([@bib44]; [@bib46]). On the other hand, the induction of the typical gene signature of IL-17-producing Vγ4^+ ^γδ T cells depends on the function of the transcription factor Sox13 ([@bib16]), while the required receptors remain elusive.

It has been known for some time that signaling pathways leading to activation of NFκB are essential for the function of various immune cell compartments (reviewed in [@bib24]). The so-called classical pathway of NFκB activation is induced mainly by molecular danger signals such as LPS or certain cytokines such as TNF or IL-1β. Non-canonical NFκB signaling, which requires the NFκB-inducing kinase (hereafter referred to as NIK, the encoding gene being *Map3k14*,) ([@bib26]; [@bib49]) is activated by a discrete subset of TNF family members, including CD40L, Lymphotoxin (LT), BAFF (B cell activating factor) and RANKL (Receptor activator of NFκB ligand). Signaling via the non-canonical pathway has been shown to fulfill roles in B cell survival ([@bib37]), activation of T cells ([@bib27]; [@bib34]), maturation and function of dendritic cells (DCs) ([@bib20]) as well as the induction of tolerance ([@bib51]; [@bib5]), but it has not been studied in the context of γδ T cell biology in detail. Previous work has suggested that signaling via the CD70-CD27 axis (which belongs to the tumor necrosis factor receptor superfamily) can activate NFκB p52 processing ([@bib35]). Also, LTβR signaling has been implicated in the differentiation program of bulk γδ thymocytes ([@bib39]), and the NFκB family members RelA and RelB were shown to guide the development of IL-17-producing Vγ4^+ ^γδ T cells ([@bib32]). Furthermore, the genesis of invariant NKT cells was claimed to depend on signaling via NIK ([@bib12]).

In the present study we set out to systematically analyze the impact of non-canonical NFκB signaling on the development and function of γδ T cells. In line with previous studies that were using knockout models of the TNF receptor family member RANKL ([@bib36]) we found that NIK-deficient mice showed a drastic loss of DETCs in the epidermis. Of note, in the absence of NIK most of the IL-17 production by splenic and lung-resident γδ T cells was lost, while their ability to express IFN-γ was not affected. Mechanistically, this was accompanied by a loss of *Rorc* and *Sox13* expression in NIK-deficient CD27^- ^γδ T cells, while in turn expression of *Tbet* and *Egr3* was increased. While previous studies reported trans-conditioning of developing γδ T cell precursors by CD4^+^ thymocytes ([@bib39]; [@bib32]), our data suggest that NIK signaling specifically in thymic epithelium is essential for shaping the cytokine profile of the γδ T cell compartment.

Results {#s2}
=======

In the absence of NIK the development of DETCs is halted in the embryonic thymus {#s2-1}
--------------------------------------------------------------------------------

Previous studies have shown that the development of DETCs is partially dependent on signaling via the RANK-RANKL axis ([@bib36]). In line with this, we observed a disturbed pool of DETCs in the epidermis of adult *Map3k14^-/-^* mice ([@bib49]), with only 30---50% of the γδ T cells present expressing the canonical Vγ5^+^ TCR ([Figure 1A](#fig1){ref-type="fig"}). Since DETCs are among the very first T cells to develop in ontogeny and populate the epidermis already prior to birth, we analyzed the epidermis of mouse embryos at day 19 post conception. Whereas there was already a prominent population of Vγ5^+^ DETCs present in WT controls, DETCs were virtually absent in the skin of NIK-deficient embryos ([Figure 1B,C](#fig1){ref-type="fig"}).10.7554/eLife.10087.003Figure 1.In the absence of NIK, the development of DETCs is blocked in the embryonic thymus.(**A**) Lymphocytes isolated from the epidermis of adult heterozygous control (left panel) and *Map3k14^-/-^* animals were analysed for the presence of Vγ5^+^ DETCs. Pregating is on live singlets and CD45^+^ CD11b^-^ cells. (**B**) Analysis of the epidermal γδ T cell compartment of heterozygous control (upper panel) and *Map3k14^-/-^* embryos (day 19 post conception) after pregating on live singlets and CD45^+^ CD11b^-^ cells. (**C**) Summary of the frequency of total γδ T cells as well as Vγ5^+^ cells within the γδ T cell gate. Data are mean +/- SD and are representative of two similar experiments. (**D**) Analysis of developing Vγ5^+^γδ thymocytes in the thymi of E19 embryos. Flow Plots have been pregated on live singlets and CD45^+^ CD4^-^ cells. Lower panel depicts the summary of the frequency of total γδ thymocytes as well as Vγ5^+^ cells within the γδ T cell gate in d19 embryonic thymi, and the median fluorescence intensity of the indicated markers. Data are mean +/- SD and representative of two similar experiments. (**E**) Analysis of the expression level of CD45RB, CD122, CD24 and CD62L on developing Vγ5^+^γδ thymocytes isolated from E19 embryonic thymi. Grey shaded histograms depict heterozygous controls, red histograms *Map3k14^-/-^* cells. Lower panel shows the summary for the frequency of positive cells for CD45RB and CD122 and the median fluorescence intensity of CD24 and CD62L, respectively. Data are mean +/- SD and are representative of two similar experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.10087.003](10.7554/eLife.10087.003)10.7554/eLife.10087.004Figure 1---figure supplement 1.DETC development in NIK-deficient thymi at embryonic day 17.(**A**) Analysis of developing Vγ5^+ ^γδ thymocytes in E17 thymi. Flow Plots have been pregated on live singlets and CD45^+^ CD4^-^ cells. Right panels depict the median fluorescence intensity of CD3 and Vγ5 expression. Data are mean +/- SD and representative of two similar experiments. (**B**) Analysis of the expression level of CD45RB on developing Vγ5^+ ^γδ thymocytes isolated from E17 embryonic thymi. Grey shaded histograms depict heterozygous controls, red histograms *Map3k14^-/-^* cells. Right panel shows the summary for the frequency of CD45RB positive cells. Data are mean +/- SD and are representative of two similar experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.10087.004](10.7554/eLife.10087.004)

The absence of DETCs in the epidermis of *Map3k14^-/-^* embryos led us to speculate that NIK-deficient DETC precursors fail to develop in the embryonic thymus. To test this notion, we analyzed thymi from *Map3k14^-/-^* and heterozygous controls at embryonic day 19 for the presence of Vγ5^+^ thymocytes. Indeed, these cells were present in NIK-deficient thymi, albeit at reduced numbers and with a consistent reduction in staining intensity of the TCR ([Figure 1D](#fig1){ref-type="fig"}). In order to assess the maturation status of the developing Vγ5^+^ thymocytes, we evaluated the expression level of various molecules that have been associated with normal DETC development, such as CD45RB, CD122, CD24 and CD62L ([@bib23]). The expected upregulation of CD45RB and CD122, which is typical for developing DETCs was not found in *Map3k14^-/-^* embryos. In turn, the downregulation of CD24 and CD62L which normally coincides with DETC maturation was also reduced ([Figure 1E](#fig1){ref-type="fig"}). Similar observations with respect to the expression of CD45RB were obtained during the analysis of thymi isolated from E17 embryos ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Taken together, the loss of NIK abrogates normal development of DETC precursors in the embryonic thymus, corroborating previous findings using knockout animals for *Tnfrsf11a* ([@bib36]).

NIK-deficient lymphoid and non-lymphoid CD27^-^γδ T cells show a selective loss of IL-17 production {#s2-2}
---------------------------------------------------------------------------------------------------

Based on the role of NIK in the formation of the epidermal DETC pool we assessed the contribution of non-canonical NFκB signaling to the development and function of other γδ T cell compartments in more detail. For comparison, throughout our study we included both targeted *Map3k14^-/-^* mice ([@bib49]) as well as *aly/aly* animals, which harbor a point mutation in NIK, expressing a dysfunctional protein ([@bib38]). Both in the spleen and the lung of these mutant animals, the total number of γδ T cells as well as the frequency of the two most prominent subclasses expressing the Vγ4^+^ and Vγ1.1^+^ TCR was unchanged. Also, the distribution of the CD27^+^ and CD27^-^ subsets of γδ T cells was indistinguishable between *Map3k14^-/-^* and heterozygous control animals ([Figure 2A--C](#fig2){ref-type="fig"}).10.7554/eLife.10087.005Figure 2.In NIK-deficient mice, γδ T cells selectively lose their ability for production of IL-17.(**A**) Flow cytometric analysis of the splenic γδ T cell compartment of heterozygous control (upper panel) and *Map3k14^-/-^* animals after pregating on live singlets and CD45^+^ CD11b^-^ B220^-^ cells. The distribution of Vγ1.1^+^, Vγ4^+^, and CD27^-^ Vγ4^+ ^γδ T cells is shown. (**B**) Summary of two independent experiments. Data represent mean +/- SD of the indicated cell subsets. (**C**) Analysis of the lung-resident γδ T cell compartment of heterozygous control (upper panel) and *Map3k14^-/-^* animals after pregating on live singlets and CD45^+^ CD11b^-^ B220^-^ cells. The distribution of Vγ1.1^+^, Vγ6^+^, and CD27^-^ Vγ6^+ ^γδ T cells is shown. (**D**) Flow cytometric analysis of IFN-γ, IL-17 and TNF-α expression by peripheral γδ T cells after PMA/Ionomycin stimulation, isolated from the spleen of heterozygous control (upper panel) and *Map3k14^-/-^* animals (lower panel). Left plots have been pregated on CD45^+^ CD11b^-^ CD4^-^ live singlets. (**E**) Summary of the frequency of cytokine producing cells within the γδ T cell compartment. Data represent mean +/- SD. (**F**) Flow cytometric analysis of IFN-γ and IL-17 expression by lung-resident γδ T cells isolated from the lung of heterozygous control (upper panel) and *Map3k14^-/-^* animals (lower panel). Left plots have been pregated on CD45^+^ CD11b^-^ CD4^-^ live singlets. (**G**) Summary of the frequency of cytokine producing cells within the lung-resident γδ T cell compartment. Data represent mean +/- SD. (**H**) Flow cytometric analysis of IFN-γ and IL-17 expression by dermal γδ T cells isolated from the skin of heterozygous control and *Map3k14^-/-^* animals. Right panel depicts the frequency of cytokine producing cells within the dermal γδ T cell compartment. Data show mean +/- SD and are representative of at least three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.10087.005](10.7554/eLife.10087.005)10.7554/eLife.10087.006Figure 2---figure supplement 1.Ratio of Vγ4^+ ^ and Vγ6^+^ cells in the lung-resident IL-17-producing γδ T cell compartment.(**A**) Flow cytometric analysis of Vγ4^+^ and Vγ6^+^ cells within IFN-γ and IL-17 expressing γδ T cells isolated from the lung of heterozygous control (upper panel) and *Map3k14^-/-^* animals (lower panel). Left plots have been pregated on CD45^+^ CD11b^-^ CD3^+^ TCRγδ^+^ live singlets. (B) Summary of the frequency of Vγ4^+^ and Vγ6^+^ cells within the lung-resident γδ T cell compartment. Data represent mean +/- SD.**DOI:** [http://dx.doi.org/10.7554/eLife.10087.006](10.7554/eLife.10087.006)

However, when we assessed the primary function of γδ T cells, which is the rapid production of pro-inflammatory cytokines, we noticed that after in vitro stimulation of bulk peripheral lymphoid γδ T cells their ability to express IL-17 was strongly diminished. In contrast, the frequency of both IFN-γ and TNF-α-producing γδ T cells was similar between *Map3k14^-/-^* and control animals ([Figure 2D,E](#fig2){ref-type="fig"}). For lung-resident γδ T cells, which include Vγ6^+ ^γδ T cells as one the most potent sources of IL-17, we also observed a reduction in the ability of NIK-deficient cells for IL-17 secretion, but this was accompanied by a slight increase in the frequency of IFN-γ production ([Figure 2F,G](#fig2){ref-type="fig"}). The ratio of Vγ4^+^ to Vγ6^+^ cells in the remaining fraction of IL-17-producing γδ T cells did not change ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Similarly, for the steady state dermal γδ T cell compartment we observed that in the absence of NIK, γδ T cells were impaired in IL-17 expression ([Figure 2H](#fig2){ref-type="fig"}).

NIK-deficiency leads to impaired *Rorc* and *Sox13* expression in CD27^-^γδ T cells {#s2-3}
-----------------------------------------------------------------------------------

To reveal the underlying mechanism for the loss of IL-17 in γδ T cells, we analyzed the expression of *Rorc* and *Il23r*, which are both necessary for normal IL-17 production ([@bib10]; [@bib44]). To this end, we purified CD27^-^ and CD27^+ ^γδ T cells ([Figure 3A](#fig3){ref-type="fig"}) from *Map3k14^-/-^* and heterozygous control animals and analyzed gene expression by qPCR. While in controls, CD27^- ^γδ T cells expressed high levels of *Ror*c and *Il23r*, the same molecules were drastically reduced in NIK-deficient CD27^- ^γδ T cells ([Figure 3B](#fig3){ref-type="fig"}), which was accompanied by an upregulation of *Tbet*. Furthermore, we assessed the expression of the transcription factors *Sox13* and *Egr3*, which have been proposed to be reciprocal regulators of γδ T17 cell development ([@bib44]; [@bib16]). While the expression level of both genes was not affected in CD27^+ ^γδ T cells, NIK-deficiency selectively in CD27^- ^γδ T cells led to a loss of *Sox13* and a gain of *Egr3* expression ([Figure 3C](#fig3){ref-type="fig"}). Collectively, these data indicate that NIK signaling is essential for RORγt and as well as Sox13 expression in CD27^- ^γδ T cells, thereby conferring their full potential for production of IL-17.10.7554/eLife.10087.007Figure 3.NIK-deficient CD27^- ^γδ T cells show reduced expression of *Rorc* and and *Sox13*.(**A**) Gating strategy used for sorting of CD27^+^ and CD27^-^γδ T cells. Right plot depicts post-sort reanalysis, which routinely yielded purities \>95%. (**B**) Analysis of the expression level of *Rorc, Il23r* and *Tbet* mRNA in sorted CD27^+^ and CD27^- ^γδ T cells isolated from the spleen of the indicated genotypes. Data represent mean +/- SD. (**C**) Analysis of the expression level of *Sox13* and *Egr3* in sorted CD27^+^ and CD27^-^ splenic γδ T cells isolated from the indicated genotypes. (**D**) Backskin thickness after Aldara treatment of heterozygous control (open triangles) and *Map3k14^-/-^* animals (closed squares). Data are representative of two independent experiments. (**E**) IL17-A and IL17-F expression of dermal γδ T cell on day 6 after Aldara treatment.**DOI:** [http://dx.doi.org/10.7554/eLife.10087.007](10.7554/eLife.10087.007)

In order to assess the functional impact of NIK-lesioned γδ T cells, we treated *Map3k14^-/-^* animals with Imiquimod, a well established system for the induction of psoriasis-like skin inflammation in mice ([@bib45]; [@bib7]; [@bib29]). After treatment with Aldara (containing 5% Imiquimod), NIK-deficient animals displayed a slight, but not significant reduction of back skin thickness ([Figure 3D](#fig3){ref-type="fig"}). Analysis of the dermal γδ T cell compartment not only revealed reduced numbers of γδ T cells (data not shown), but also a significant reduction of both IL-17A and IL-17F expression by γδ T cells ([Figure 3E](#fig3){ref-type="fig"}). This suggests that NIK-signaling also in an inflammatory setting is essential for full IL-17 production by γδ T cells, but that other cell types, such as ILCs ([@bib29]) can compensate this functional impairment during Aldara induced skin inflammation.

Targeted deletion of NIK in mTECs, but not in γδ T cells causes abnormal DETC development {#s2-4}
-----------------------------------------------------------------------------------------

While our data and work from others ([@bib36]) clearly suggest a non-redundant role of non-canonical NFκB signaling in the development of DETCs, it has so far not been possible to determine whether NFκB signaling occurs in a γδ T cell intrinsic or extrinsic manner. To dissect the contribution of different cellular compartments *in vivo*, we generated a novel conditional mouse mutant that allows cell-type specific deletion of the *Map3k14* gene using the Cre/LoxP system. *Map3k14^flox/wt^* animals were generated by gene targeting in embryonic stem (ES) cells, thereby inserting LoxP sites up- and downstream of Exon 4 and 6 of the *Map3k14* gene locus, respectively (Supp. [Figure 1](#fig1){ref-type="fig"}). These mice were first crossed to a Deleter-Cre strain, followed by breeding the deleted locus to homozygosity. Examination of the resulting *Map3k14^del/del^* mice showed that these mice were lacking lymph nodes, suggesting that the conditional construct is working as expected ([Figure 4A](#fig4){ref-type="fig"}). To further verify the phenotype of *Map3k14^del/del^* mice, we compared the cytokine production of peripheral γδ T cells to WT and *Map3k14^-/-^* animals, showing that *Map3k14^del/del^* mice phenocopy the full knockout ([Figure 4B](#fig4){ref-type="fig"}). The same was true for the epidermal DETC pool ([Figure 4C](#fig4){ref-type="fig"}).10.7554/eLife.10087.008Figure 4.Conditional deletion of NIK in mTECs causes impaired DETC development.(**A**) *Map3k14^flox/wt ^*mice have been crossed to Deleter Cre animals for deletion of the Loxp flanked gene locus. After subsequent breeding to homozygosity, *Map3k14^del/del^* mice were analyzed for the presence of lymph nodes. Upper panel depicts heterozygous controls. (**B**) Splenic γδ T cells from control, *Map3k14^-/-^* and *Map3k14^del/del^* mice were assessed for production of IL-17 (left panel) and IFN-γ (right panel) by intracellular cytokine staining. (**C**) The epidermal γδ T cell compartment of control, *Map3k14^-/-^* and *Map3k14^del/del^* animals was assessed for the frequency of Vγ5^+^ DETCs. (**D**) Lymphocytes isolated from the epidermis of adult control (upper panel), *Map3k14^-/-^* and *Ccl19-Cre^+^ Map3k14^flox/flox^* animals were analysed for the presence of Vγ5^+^ DETCs. Pregating is on live singlets and CD45^+^ cells. Right panel depicts the summary of the frequency of total γδ T cells as well as Vγ5^+ ^γδ T cells in the epidermis of Control, *Map3k14^-/-^* and *Ccl19-Cre^+^ Map3k14^flox/flox^* animals. Data represent mean +/- SD. (**E**) Frequency of total γδ T cells in the skin of 12---13 day old control littermates and *Foxn1-Cre^+^ Map3k14^flox/flox ^*animals. Data represent mean +/- SD and is pooled from several independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.10087.008](10.7554/eLife.10087.008)10.7554/eLife.10087.009Figure 4---figure supplement 1.Targeting strategy used for generation of the conditional *Map3k14^flox/wt^* strain.(**A**) Schematic representation of the targeted *Map3k14* gene locus showing the position of the Loxp Sites flanking exon 4---6. Abbreviations are denoted in the figure. (**B**) Schematic representation of the *Map3k14* locus after Cre-mediated recombination, leading to a frameshift and a stop codon in exon 7.**DOI:** [http://dx.doi.org/10.7554/eLife.10087.009](10.7554/eLife.10087.009)

As a next step, we assessed whether the DETC defect observed in complete NIK-knockout animals is due to the requirement for NIK signaling in thymic epithelial cells. To specifically delete NIK in medullary thymic epithelial cells (mTECs), *Map3k14^flox/flox^* mice were crossed to *Ccl19-Cre* mice, which express Cre solely in lymph node stromal cells and mature medullary thymic epithelial cells ([@bib8]; [@bib28]). *Ccl19-Cre^+^ Map3k14^flox/flox^* animals phenocopied the aberrant DETC development observed in germline *Map3k14^-/-^* mice, with a loss of Vγ5 expression by DETCs ([Figure 4D](#fig4){ref-type="fig"}). However, we observed some variation in the penetrance of the Ccl19-Cre transgene, with some litters presenting with a phenotype, while others did not, suggesting that the start of Cre expression driven by *Ccl19* promotor sharply coincides with the start of DETC development in the embryo. Thus, we decided to utilize an additional strain targeting the thymic epithelium, namely *Foxn1-Cre* mice in which Cre is under control of the *Foxn1* promotor and thus active in all thymic epithelial cells (both cortical and medullary) ([@bib14]). Corroborating our findings, *Foxn1-Cre^+^ Map3k14^flox/flox^* showed a strong reduction in both frequency and number of skin-resident TCRγδ^high^ DETCs ([Figure 4E](#fig4){ref-type="fig"}).

NIK signaling specifically in thymic epithelial cells is essential for the formation of the IL-17-producing γδ T cell pool {#s2-5}
--------------------------------------------------------------------------------------------------------------------------

To assess which cellular compartment requires NIK for the formation of IL-17 committed γδ T cells, we first deleted NIK specifically in CD27^- ^γδ T cells using *Rorc-Cre^+^ Map3k14^flox/flox^* animals. Analysis of Fatemap *Rorc-Cre^+^ R26-Stop-flox-YFP* mice showed that around 90% of CD27^- ^γδ T cells in the lung expressed yellow fluorescent protein (YFP), indicating a good targeting efficiency of this cellular subset ([Figure 5A](#fig5){ref-type="fig"}). However, lung-resident γδ T cells in *Rorc-Cre^+^ Map3k14^flox/flox^* mice expressed IL-17 at levels comparable to wildtype controls ([Figure 5B](#fig5){ref-type="fig"}), suggesting that γδ T cell intrinsic signaling is dispensable for the commitment of IL-17-producing γδ T cells. To exclude a potential role of NIK signaling in the CD4^+ ^αβ thymocyte compartment ([@bib32]), we analyzed both peripheral and lung-resident γδ T cells in *CD4-Cre^+^ Map3k14^flox/flox^* mice. Their ability for IL-17 production was comparable to wildtype controls ([Figure 5C](#fig5){ref-type="fig"}), demonstrating that also within the αβ thymocyte compartment NIK signaling is dispensable.10.7554/eLife.10087.010Figure 5.Conditional deletion of NIK in TECs causes not only a loss of DETCs, but also IL-17-producing γδ T cells.(**A**) γδ T cells were isolated from the lung of *Rorc-Cre^+^ R26-Stop-flox YFP*-mice and assessed for the frequency of YFP^+^ cells within the CD27^-^γδ T cell compartment. (**B**) Lung-resident γδ T cells from adult control, *Map3k14^-/-^* and *Rorc-Cre^+^ Map3k14^flox/flox^* mice were assessed for production of IL-17 (left panel) and IFN-γ (right panel) by intracellular cytokine staining. (**C**) Lung-resident γδ T cells from adult control and *CD4-Cre^+^ Map3k14^flox/flox^* mice were assessed for production of IL-17 (left panel) and IFN-γ (right panel). (**D**) Lung-resident as well as splenic γδ T cells from adult control and *Ccl19-Cre^+^ Map3k14^flox/flox^* mice were assessed for production of IL-17 and IFN-γ. Data is representative of three independent experiments. (**E**) Frequency of IL-17-producing γδ T cells in the lung of 12---13 day old control littermates and *Foxn1-Cre^+^ Map3k14^flox/flox^* animals, plots have been pregated on live CD45^+^ singlets, CD3^+^ TCRγδ^+^ cells. Right panels depict the summary of several independent experiments for cytokine production in the lung (left) and spleen (right). Data are mean +/- SD.**DOI:** [http://dx.doi.org/10.7554/eLife.10087.010](10.7554/eLife.10087.010)

Based on these results we speculated whether loss of NIK signaling in TECs will impact on the commitment of IL-17-producing γδ T cells. To this end, we analyzed the lung-resident γδ T cell compartment of both *Ccl19-Cre^+^ Map3k14^flox/flox^* and *Foxn1-Cre^+^ Map3k14^flox/flox^* mice. While γδ T cells isolated from the lung of *Ccl19-Cre^+^ Map3k14^flox/flox^* animals did not present with any abnormalities in cytokine production, γδ T cells isolated from P13 *Foxn1-Cre^+^ Map3k14^flox/flox^* mice showed significant defects in their ability for IL-17 production both in the spleen and lung ([Figure 5D](#fig5){ref-type="fig"}), suggesting that indeed NIK signaling in thymic epithelial cells is needed for imprinting the cytokine commitment onto developing γδ T cells.

Discussion {#s3}
==========

In the past years, γδ T cells have attracted growing interest due to their unique features that place them at the interface of adaptive and innate immunity. Nevertheless, in contrast to αβ T cells, the signaling events underlying γδ T cell development and activation are much less understood (reviewed in [@bib33] and [@bib46]). Here, we have shown *in vivo* that NIK signaling in thymic epithelial cells is essential for the full function of two different γδ T cell populations, namely skin-resident DETCs as well as CD27^-^ IL-17-producing γδ T cells.

Previous work has suggested an involvement of the NFκB-inducing kinase in the differentiation of both αβ and γδ T cells ([@bib13]). Contrary to the findings by Eshima and colleagues we could not observe a consistent overall reduction in the number of γδ T cells (except the DETC pool), yet we observed functional impairment of CD27^-^ IL-17-producing γδ T cells. This discrepancy might result from two mutually non-exclusive explanations: first, *aly/aly* mice as well as *Map3k14^-/-^* mice due to their complex phenotype (including impairment of thymic negative selection) are prone to develop some degree of tissue inflammation over time, which is accompanied by an expansion of both CD4^+^ and CD8^+^ cells ([@bib43]; [@bib21]; [@bib51]) and could thereby induce a relative decrease in the proportion of γδ T cells. Second, it has recently been established that the γδ T cell compartment cannot be fully reconstituted using bone-marrow chimeric animals ([@bib15]; [@bib18]). Using a genetic model that allows the cell-type specific deletion of NIK avoids all these confounding phenotypes of mice in which the gene locus of NIK (*Map3k14*) has been deleted in the germ-line.

Two members of the TNFR family, namely CD40 and RANK, have been implicated both in the development of DETCs and full maturation of mTECs ([@bib19]; [@bib1]). In embryogenesis, these events occur at similar time points post conception, and it seems that in the embryonic thymus, developing DETC precursors signal via the RANKL-RANK axis to immature mTECs, inducing their full maturation to Aire^+^ MHC-II^high^ mTECs ([@bib36]). Hence, *Tnfrsf11a^-/-^* mice have reduced numbers of DETCs. Given that NIK is downstream of RANK ([@bib11]), one would expect a similar phenotype in *Map3k14^-/-^* animals, but the DETC deficiency that we observed in newborn *Map3k14^-/-^* mice was much more pronounced than in *Tnfrsf11a^-/-^* animals, suggesting that during DETC development several upstream receptors converge in their signaling to NIK, making it a key pathway during thymic DETC development. Importantly, our data obtained using the conditional NIK-mutant strongly suggests that for normal function of the γδ T cell compartment, NIK signaling does not act γδ cell-intrinsically but in trans by its function in thymic epithelial cells. Conditional deletion of NIK solely in thymic epithelial cells was sufficient to copy the DETC phenotype seen in complete germ-line NIK-knockout animals. We believe this to be the first genetic *in vivo* demonstration that non-canonical NFκB signaling is not required in DETCs in a cell-intrinsic manner, but through its activity in TECs.

The ability of CD27^- ^γδ T cells to rapidly produce IL-17 even after being activated only by cytokines ([@bib42]; [@bib34]) has been the focus of intense research. Only the neonatal thymic microenvironment appears to have the capacity to imprint a stable cytokine profile to γδ T cells, since the IL-17-producing γδ T cell subsets cannot be reconstituted in adult animals by bone marrow transfer ([@bib18]). Very recently, a hallmark paper has provided mechanistic insights into how this can be achieved: during embryonic development of certain γδ T cell subsets, the signaling threshold for activation of the TCR becomes markedly altered ([@bib47]). Hence, mature γδ T cells do not necessarily rely on a TCR stimulation as "'signal one"', although they can still respond to that ([@bib41]).

However, while this intriguing mechanism ([@bib47]) explains the behavior of several γδ T cell subsets, the thymic cues orchestrating this hard-wiring of γδ T cells remain unclear. Previous work suggested either LTβR-dependent trans-conditioning by double positive thymocytes or γδ T cell intrinsic RelB activation ([@bib39]; [@bib32]). Further work by Silva-Santos and colleagues emphasized the role of TNF-receptor family members such as CD27 as well as NFκBp52 activation ([@bib35]). However, the contribution of thymic stromal cells to these processes has not been experimentally addressed *in vivo*. Our data suggest that NFκB signaling via NIK seems to be dispensable both within CD27^- ^γδ T cells as well as αβ T cells, at least for their ability for expression of pro-inflammatory IL-17. Of note, deletion of NIK in all thymic epithelial cells using *Foxn1-Cre* phenocopied the complete NIK-knockout in terms of IL-17 expression by CD27^-^γδ T cells, while this was not the case using *Ccl19-Cre*. The latter has been reported to target only maturing medullary thymic epithelial cells ([@bib28]). This would suggest that the instruction of γδ T cells is mediated by early or junctional TECs, or that the timing of *Ccl19-Cre*-mediated recombination sharply coincides with the expression of the γδ T cell instructing program in TECs. Based on our observation that NIK signaling in the early thymic stroma has a profound and long-lasting effect on the maturation and cytokine profile of developing γδ T cells, further studies are required in order to precisely define the nature of γδ T cell instructing molecules, and which thymic epithelial cell type is required for delivery. While our data does not exclude a role for canonical-NFκB signaling via RelA ([@bib32]), the impact of non-canonical signaling via NIK on the development of DETC precursors and IL-17-producing γδ T cells stems from signaling within the thymic stroma, for which the conditional NIK mutant is a unique tool for further studies. Future work will reveal whether NIK-deficient thymic stroma influences only γδ T cell development, or also the functional profile of the subsequently emerging αβ T cell compartment.

Materials and methods {#s4}
=====================

Mice and animal experiments {#s4-1}
---------------------------

C57Bl/6 (wildtype) mice were purchased from Jackson Laboratories and bred in-house at the Laboratory Animal Science Center (LASC) of the University of Zurich under specific pathogen-free (SPF) conditions. *Map3k14^-/-^* mice were kindly provided by Robert Schreiber (Washington University School of Medicine, USA), backcrossed to C57Bl/6 background and bred in-house. Alymphoplasia mice (here referred to as *aly/aly*) were obtained from Clea Laboratories (Japan) and bred in-house. *Map3k14^flox/wt^* mice were generated in collaboration with the lab of Ari Waisman (University of Mainz, Germany) by TaconicArtemis. Briefly, a targeting vector containing the Loxp-flanked Exons 4---6 of the *Map3k14* loucs was introduced into embryonic stem (ES) cells, ES cell clones with homologous integration were selection and injected into blastocytes ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). *Ccl19-Cre* mice were generated in the lab of Burkhard Ludewig (Institute of Immunobiology, St. Gallen, Switzerland) by Lucas Onder ([@bib8]). *Foxn1-Cre* mice were purchased from Jackson ([@bib14]). For the induction of psoriasis-like skin inflammation 55 mg of Aldara (containing 5% of Imiquimod) was applied to the shaved back skin of animals. Treatment of animals as well as measurement of skin thickness was done blinded. All animal experiments were approved by local authorities (Swiss cantonal veterinary office Zurich, KVET license numbers 86/2012, 70/2015, 100/2015 and 68/2013) and performed in strict accordance with the corresponding license.

Lymphocyte isolation from the skin and lung {#s4-2}
-------------------------------------------

Unless stated otherwise, ears were taken as the donor organ. Ears were split into dorsal and ventral sides using forceps, followed by incubation with Dispase (2.4 mg/ml, Gibco) in HBSS with Ca^2+^/Mg^2+^ at 37°C for 90 min Epidermal sheets were removed from the dermis, cut into small pieces using scissors and further digested using Collagenase Type 4 (0.4 mg/ml, Sigma) in HBSS with Ca^2+^/Mg^2+^ and 10% FCS at 37°C for 60---90 min The resulting suspension was mechanically disrupted using 19 g needles and a syringe. After filtering, the cell suspension was used in downstream applications.

Lungs were isolated, cut into small pieces using scissors and further digested using Collagenase D (0.5 mg/ml, Roche) in RPMI with 2% FCS and 25 mM HEPES. The resulting suspension was mechanically disrupted using 19 g needles and a syringe, followed by filtering and downstream analysis.

Lymphocyte isolation from embryonic thymi {#s4-3}
-----------------------------------------

After setting up timed matings o/n, female mice were observed for signs of pregnancy, sacrificied on the indicated time points and embryos were isolated and euthanized by decapitation. The day after timed mating was considered day 0. Embryonic thymi were collected using fine forceps and a stereo microscope (Leica), and then dissociated by mechanical disruption using a cell strainer and a syringe pistil.

Flow cytometry {#s4-4}
--------------

Flow cytometric analysis was performed following standard methods (reviewed in [@bib30]). All flourochrome-conjugated antibodies used were obtained either from BD (NJ, USA), BioLegend (CA, USA) or eBioscience (CA, USA). In all stainings, dead cells were excluded using an Aqua or Near-IR Live/Dead fixable staining reagent (Life Technologies, now Thermo Fisher Scientific, MA, USA / BioLegend), and doublets were excluded by FSC-A vs FSC-H gating. For intracellular cytokine staining, cells were incubated 4 hours in IMDM containing 10% FCS with PMA (50 ng/ml) / Ionomycin (500 ng/ml) and GolgiPlug (Brefeldin A, BD). Cytofix/Cytoperm (BD) was used according to the manufacturers instructions, and Perm/Wash buffer was prepared in the lab (PBS containing 0.5% Saponin and 5% BSA). Analysis was performed using a LSR II Fortessa (special order research product, BD, equipped with 405 nm, 488 nm, 561 nm and 640 nm laser lines), cell sorting was carried out using a FACSAria III (BD). Data analysis was performed using FlowJo V9.x and 10.0.x (Treestar, OR, USA).

qPCR analysis {#s4-5}
-------------

Indicated cellular subsets were sort purified and collected in Trizol reagent. Afterwards, RNA was isolated using PureLink RNA Micro Kit (Thermo Fisher Scientific) following the manufacturers instructions. The eluted RNA was transcribed into cDNA using M-MLV reverse transcriptase (Thermo Fisher Scientific) or Superscript II (Thermo Fisher Scientific) and random primers. cDNA was diluted either 1:5 or 1:10 and used for qPCR with iTaq Universal SYBR Green Supermix (BioRad, CA, USA) and a BioRad C1000Touch / CFX384 real-time system according to the manufacturers instructions. The used primers (intron-spanning) were as follows:

*PolR2a* (145 bp): CTGGTCCTTCGAATCCGCATC

 GCTCGATACCCTGCAGGGTCA

*Map3k14* (164 bp): CGAAACTGAGGACAACGAG

 CACACTGGAAGCCTGTCTG

*Skint-1* (143 bp): TTCAGATGGTCACAGCAAGC

 GAACCAGCGAATCTCCATGT

*Rorc* (114 bp): CATATGCCTCTCTGACAGAC

 AAAAGAGGTTGGTGCGCTG

*Tbet*: CAACAACCCCTTTGCCAAAG

 TCCCCCAAGCAGTTGACAGT

*Egr3*: CAACGACATGGGCTCCATTC

 GGCCTTGATGGTCTCCAGTG

*Sox13*: GCTTTACCTATTCAGCCCAT

 ACCTCTTCACCACAGGGG

Statistical analysis {#s4-6}
--------------------

Unless stated otherwise, data is displayed as mean +/- standard deviation.

Statistical calculations were performed using GraphPad Prism, and significance was calculated using an unpaired t-test unless stated otherwise.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for submitting your work entitled \"Signaling via the NFκB-inducing kinase is essential for the function of skin-resident and IL-17 producing γδ T cells\" for peer review at *eLife*. Your submission has been favorably evaluated by Tadatsugu Taniguchi (Senior editor), Fiona Powrie (Reviewing editor) and two reviewers.

The reviewers have discussed the reviews with one another and the Reviewing editor has drafted this decision to help you prepare a revised submission.

Mair and colleagues analyzed γδ T cells in NIK-deficient mice and observed two interesting defects:

1\) The embryonic development of γ5δ1 epidermal T cells is strongly affected;

2\) The IL-17 production capacity of γ4 and γ6 CD27^-^ T cells in spleen and lung is markedly reduced, together with a reduction of Rorc and the receptor for IL-23.

Experiments with a novel conditional knockout crossed with a Cre deleter expressed in lymph node stroma and medullary thymic epithelial cells demonstrated that NIK signaling is required in a cell extrinsic fashion, for the development of γ5. Conditional knockout crossed with a FoxN1-deleter, which acts both in cortical and medullary thymic epithelia showed a defect of IL-17 production capacity of γδ T cells.

This study is interesting, well-organized and performed. It contains a substantial amount of work, is technically sound and advances our understanding of T cell development.

Specific comments:

1\) There are reservations regarding the novelty of this study, because of a previous study published in Immunology in 2014 by Eshima et al., which shows a defect of γδ T cells in Nik-deficient mice. This paper is not cited and should be discussed.

2\) A major conceptual gap which is neither addressed nor properly discussed is which upstream receptor(s) control NIK activity in CD27^-^ γδ T cells. Is it LTbR? Or RANK? The issue of upstream receptors is also relevant for DETC development since NIK^-/-^ mice have a stronger phenotype than RANK^-/-^ animals. The authors should at a minimum discuss these issues carefully. Another possibility would be to stimulate thymic stroma (from FTOC) with agonists for these receptors and biochemically check NIK activation.

3\) [Figure 2](#fig2){ref-type="fig"} shows reduced IL-17 producers in the spleen and lung of NIK^-/-^ mice. What about the dermis -- in steady-state and upon psoriasis induction -- a model fully established in the Becher lab? Furthermore, how is the disease scored in these animals (if there is an IL-17 phenotype in the dermis)?

4\) [Figure 4](#fig4){ref-type="fig"}: what is the embryonic THYMIC Vγ5^+^ phenotype (at E15-E16) of the CCL19-conditional NIK^-/-^ mice?

5\) [Figure 5](#fig5){ref-type="fig"}: in comparison with FoxN1-conditional NIK^-/-^ mice, what is the SPLENIC IL-17 phenotype of CCL19-conditional NIK^-/-^ animals? (This could also be shown in [Figure 4](#fig4){ref-type="fig"}).

6\) The title is misleading: the effect on skin-resident γδ T cells (DETC) is not functional, but rather developmental/maturation.

7\) The authors should cite Ribot et al., J Immunol, 2010 in the fifth paragraph of the Introduction when discussing the role of non-canonical NKkB signalling in γδ T cell biology. This paper shows that CD27 costimulation of CD27^+^ γδ T cells activates non-canonical NF-kB signalling.

8\) In the second paragraph of the subsection "In the absence of NIK the development of DETCs is halted in the embryonic thymus", when describing [Figure 1D](#fig1){ref-type="fig"}: the difference in numbers of Vγ5^+^ thymocytes is *not* significant. The drop in total γδ thymocytes ([Figure 1D](#fig1){ref-type="fig"}) must therefore be due to non-Vγ5^+^ cells. This should be qualified. Given the subsequent clear-cut data in [Figure 1E](#fig1){ref-type="fig"}, the text should clarify a maturation defect in thymic development of DETC precursors, which likely accounts for the skin phenotype ([Figure 1B](#fig1){ref-type="fig"}).

9\) [Figure 1](#fig1){ref-type="fig"}: Vγ5^+^ thymocyte development peaks at E15-E16, not at E19 when the analysis was performed. The authors should analyse this earlier ontogeny stage for proper assessment of DETC precursor development (rather than thymic maintenance).

10\) [Figure 2F](#fig2){ref-type="fig"}: did the authors check the Vγ4 versus Vγ6 repertoire of IL-17+ γδ T cells in the lung of NIK^-/-^ and control mice?

11\) Discussion: The authors should qualify their conclusion as follows \"the impact of non-canonical signaling via NIK on the development of DETC precursors and IL-17-producing γδ T cells stems from signaling within the thymic stroma\". They cannot generalize this conclusion to other aspects of γδ T cell development which were not addressed in this study.

10.7554/eLife.10087.012

Author response

Specific comments:

*1) There are reservations regarding the novelty of this study, because of a previous study published in Immunology in 2014 by Eshima et al., which shows a defect of γδ T cells in Nik-deficient mice. This paper is not cited and should be discussed.*

We apologize for not including the work by Eshima et al. in our original reference list. However, this study investigates the mere presence or absence of γδ T cells in various organs, and has in our opinion the following limitations: First and foremost, bone marrow chimeric mice do not permit the study of γδ T cell development and function, because chimeric mice do not reconstitute all γδ T cell compartments (Haas et al., Immunity, 2012 and Gray et al., JI, 2011). Second, neither in Materials and methods nor in the figure legend ([Figure 4](#fig4){ref-type="fig"}) do Eshima et al. state how the absolute numbers of γδ T cells have been measured and calculated. In our hands, systematic quantification of the γδ T cell pool in large numbers of NIK^-/-^ mice never showed such a drastic reduction of absolute γδ T cell counts in spleen, blood or lung. The relative reduction of TCRγδ^+^ cells within the CD3 gate could also be explained by an expansion of CD4^+^ and CD8^+^ T cells. We have included and discussed the study by Eshima et al. in our revised manuscript.

*2) A major conceptual gap which is neither addressed nor properly discussed is which upstream receptor(s) control NIK activity in CD27^-^ γδ T cells. Is it LTbR? Or RANK? The issue of upstream receptors is also relevant for DETC development since NIK^-/-^ mice have a stronger phenotype than RANK^-/-^ animals. The authors should at a minimum discuss these issues carefully. Another possibility would be to stimulate thymic stroma (from FTOC) with agonists for these receptors and biochemically check NIK activation.*

We regret to not have clarified this important point better. Based on our analysis of the conditional NIK allele, NIK signaling neither within γδ T cells nor in αβ T cells is required for the expression of IL17. Instead, only the TEC-specific knockout of NIK led to a loss of IL17 secretion by γδ T cells. Hence, at least for this function of γδ T cells, γδ T cell intrinsic NIK activity is not essential.

We have revised the discussion of this aspect in our revised manuscript in order to state clearly that NIK signaling probably via activation of LTβR and RANK in thymic epithelial cells is required for IL-17 secretion by γδ T cells.

*3) [Figure 2](#fig2){ref-type="fig"} shows reduced IL-17 producers in the spleen and lung of NIK^-/-^ mice. What about the dermis -- in steady-state and upon psoriasis induction -- a model fully established in the Becher lab? Furthermore, how is the disease scored in these animals (if there is an IL-17 phenotype in the dermis)?*

We have performed additional experiments to analyze the cytokine production by γδ T cells in the dermis, as well as the clinical response of NIK-deficient mice to Aldara-induced skin inflammation. We found that during steady state the functional impairment of NIK-deficient dermal γδ T cells was comparable to the lung γδ T cell compartment. This resulted in a minor change in clinical score after Aldara-induced skin inflammation and a modest albeit not significant reduction of skin thickness. One likely explanation is that innate lymphocytes also contribute to the delivery of IL-17 and IL-22 to the inflamed skin and are likely to compensate for the loss of γδ T cell derived IL-17 (Pantelyushin et al., JCI, 2012).

These additional datasets have been included and discussed in the revised version of the manuscript.

*4) [Figure 4](#fig4){ref-type="fig"}: what is the embryonic THYMIC Vγ5^+^ phenotype (at E15-E16) of the CCL19-conditional NIK^-/-^ mice?*

We have attempted those experiments over the past months and observed that the timing of CCL19-Cre mediated recombination of the NIK gene locus in our hands appears too variable to draw definitive experimental conclusions. That is the reason why we decided to target thymic epithelial cells using FoxN1-Cre, which is active earlier and in our hands had a consistent penetrance. We have discussed this aspect in the context of point 5 and amended the Discussion of our manuscript accordingly.

*5) [Figure 5](#fig5){ref-type="fig"}: in comparison with FoxN1-conditional NIK^-/-^ mice, what is the SPLENIC IL-17 phenotype of CCL19-conditional NIK^-/-^ animals? (This could also be shown in [Figure 4](#fig4){ref-type="fig"}).*

This astute question relates also to point 4. Our analysis of the IL17-production by splenic γδ T cells in CCL19-Cre NIK^flox/flox^ mice showed no difference compared to littermate controls. This is in contrast to our observations with FoxN1-Cre NIK^flox/flox^ animals, and in all likelihood a result of the different time points of Cre expression during development in these two strains: while FoxN1-Cre targets all TECs from an early embryonic stage onwards (Gordon et al., BMC Dev Biol., 2007), CCL19-Cre is active only in maturing mTECs (Onder et al., EJI, 2015). Since the "window" for the development of IL-17-producing γδ T cells is tightly regulated within an early stage in the embryonic thymus (Haas et al., Immunity, 2012), this would explain our observations using these two different Cre lines. In addition, as mentioned above, we have observed variability in the penetrance of the CCL19 transgene, which might also reflect the delicate timing in the development of the thymic medulla (Onder et al., EJI, 2015). We have included and discussed the data obtained from CCL19-Cre NIK^flox/flox^ splenic γδ T cells in the revised manuscript.

*6) The title is misleading: the effect on skin-resident γδ T cells (DETC) is not functional, but rather developmental/maturation.*

We agree and have changed our title to "The NFκB-inducing kinase is essential for the developmental programming of skin-resident and IL-17-producing γδ T cells".

*7) The authors should cite Ribot et al., J Immunol, 2010 in the fifth paragraph of the Introduction when discussing the role of non-canonical NKkB signalling in γδ T cell biology. This paper shows that CD27 costimulation of CD27^+^ γδ T cells activates non-canonical NF-kB signalling.*

We agree; the work by Ribot et al. has been included in the Introduction as well as the revised Discussion of our manuscript.

*8) In the second paragraph of the subsection "In the absence of NIK the development of DETCs is halted in the embryonic thymus", when describing [Figure 1D](#fig1){ref-type="fig"}: the difference in numbers of Vγ5^+^ thymocytes is* not *significant. The drop in total γδ thymocytes ([Figure 1D](#fig1){ref-type="fig"}) must therefore be due to non-Vγ5^+^ cells. This should be qualified. Given the subsequent clear-cut data in [Figure 1E](#fig1){ref-type="fig"}, the text should clarify a maturation defect in thymic development of DETC precursors, which likely accounts for the skin phenotype ([Figure 1B](#fig1){ref-type="fig"}).*

Indeed, the data suggest a maturation defect of DETC precursors, as suggested by the insignificant difference in the numbers of Vγ5+ thymocytes. We have changed the wording in the revised version accordingly and discussed this aspect in the context of our experiments with E17 embryonic thymi (see [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} and point 9 below).

*9) [Figure 1: V](#fig1){ref-type="fig"}γ5^+^ thymocyte development peaks at E15-E16, not at E19 when the analysis was performed. The authors should analyse this earlier ontogeny stage for proper assessment of DETC precursor development (rather than thymic maintenance).*

Unfortunately, within the past two months our attempts with timed pregnancies were unsuccessful, and we could not obtain a sufficient number of NIK-deficient E16 embryos. However, in our revised manuscript we have included previously generated data on the development of Vγ5^+^ DETC precursors in E17 thymi ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We hope that the E17 data, which show similarly impaired development of DETC precursors as on E19, will satisfy this referee. However, we are continuing to attempt analysis of earlier time points. We leave it to the editor to decide whether E17 data are sufficient or whether E16 data are still required. To do so we would require an additional 6-8 weeks in order to set up more timed pregnancies.

*10) [Figure 2F](#fig2){ref-type="fig"}: did the authors check the Vγ4 versus Vγ6 repertoire of IL-17+ γδ T cells in the lung of NIK^-/-^ and control mice?*

We have performed additional experiments to investigate this and observed that although, as reported, the overall frequency of IL-17-producing γδ T cells in the lung of NIK^-/-^ mice was consistently reduced, the relative proportion of Vγ4^+^ and Vγ6^+^ cells within this pool remained unaltered. We have included this dataset in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}.

*11) Discussion: The authors should qualify their conclusion as follows \"the impact of non-canonical signaling via NIK on the development of DETC precursors and IL-17-producing γδ T cells stems from signaling within the thymic stroma\". They cannot generalize this conclusion to other aspects of γδ T cell development which were not addressed in this study.*

We apologize for this generalization and have rephrased our conclusions based on your suggestion.

In addition to the above mentioned points we have generated new data showing not only that the expression of RORc and IL23R are affected in NIK-deficient CD27^-^γδ T cells, but also the expression of the essential transcription factors Sox13 (Gray et al., Nat Immunol., 2013) and Egr3 (Turchinovic, Immunity, 2011) is deregulated in NIK-deficient CD27^-^γδ T cells. We have incorporated these additional data sets in [Figure 3](#fig3){ref-type="fig"}.

Also, as suggested, we have hyphenated "IL-17-producing" as well as "NFkB-inducing" throughout our text. Furthermore, when addressing gene deficient mice, we have replaced "NIK" with the official name of the gene locus, Map3k14.
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